Community-engaged partnership to reduce COVID-19 through self-testing in Hispanic and NHPI communities
Project Number3R01MD013852-03S2
Former Number5R01MD013852-03
Contact PI/Project LeaderMCELFISH, PEARL
Awardee OrganizationUNIV OF ARKANSAS FOR MED SCIS
Description
Abstract Text
Abstract
The racial/ethnic disparities in Northwest Arkansas (Benton and Washington Counties) were so stark that
the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health sent investigators.
The CDC's report documented that 45% of all adult cases in Northwest Arkansas were among Hispanic/Latinx
patients and 19% were Native Hawaiian/Pacific Islander (NHPI) patients.1 Hispanic/Latinxs and NHPIs only
account for 17% and 2.4% of the two-county population, respectively. COVID-19 deaths in Northwest Arkansas
were also disparate across race and ethnicity. NHPI deaths were estimated to be more than 200 per 100K —
much higher than the overall death ratio for the county of 5.10 per 100K, as well as the death ratio for Whites
of 4.03 per 100K.1 Among racial/ethnic minorities, the Northwest Arkansas NHPI population stands out as
having much higher odds of death from COVID-19.1 Even with the increased availability of COVID-19 testing
and vaccination, barriers remain for racial and ethnic minority populations. While the availability of COVID-19
testing has improved, disparities in testing across race, ethnicity, and socioeconomic status continue to stymie
efforts to reduce COVID-19 morbidity and mortality. Hispanic/Latinx and NHPIs have also experienced
increased discrimination related to COVID-19. Our preliminary research documents that these experiences
with discrimination may reduce Hispanic/Latinx and NHPI willingness to get tested. Minority populations are
more likely to distrust traditional approaches to health care. In addition to concerns with trust and
discrimination, Hispanic/Latinx and NHPI community members face access barriers including long-working
shifts, inability to take off work for health care, and lack of insurance. Self-testing for COVID-19 holds promise
in overcoming the barriers of trust, discrimination, and health care access. Yet no studies have tested the best
distribution methods for self-testing among Hispanic/Latinx and NHPI. This study fills that gap and holds
promise for increasing sustained access for Hispanic/Latinx and NHPI communities and reducing significant
COVID-19 disparities in incidence, hospitalization, and death. Our specific aims are: Aim 1. Leverage and fully
engage our long-standing community-based partnerships to overcome barriers of trust, discrimination, and
health care access to increase the use of COVID-19 self-testing. Aim 2. Implement and evaluate access and
uptake strategies of two self-testing distribution approaches (local community clinics and community-based
non-profit organizations) to understand effectiveness and impact for vulnerable populations. Aim 3. Fully
collaborate with the RADx-UP Coordination and Data Collection Center (CDCC) and other RADx sites.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE
The increase in COVID-19 self-testing holds promise in overcoming the barriers of trust, discrimination, and
health care access Native Hawaiian and Pacific Islanders (NHPI) and Hispanic/Latinx experience. The
interdisciplinary team will implement and evaluate access and uptake strategies of two self-testing distribution
approaches (local community clinics and community-based non-profit organizations) to understand
effectiveness and impact for vulnerable populations. This study fills gaps in the research related to self-testing
and holds promise for increasing sustained access for NHPI and Hispanic/Latinx communities and reducing
significant COVID-19 disparities in incidence, hospitalization, and death.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdultArkansasBudgetsCOVID-19COVID-19 disparityCOVID-19 morbidityCOVID-19 mortalityCOVID-19 testingCOVID-19 vaccinationCenters for Disease Control and Prevention (U.S.)Cessation of lifeCommunicationCommunitiesCountyDataData CollectionDiscriminationEffectivenessEthnic OriginEventFaceFundingGrantHealthcareHispanicsHospitalizationIncidenceInsuranceKnowledgeLatinxLeadLocationMethodsMinority GroupsMonitorNative HawaiianNonprofit OrganizationsOccupationsPacific Island AmericansPatientsPoliciesPopulationPublicationsRADxRADx Underserved PopulationsRaceRecording of previous eventsReport (document)ReportingResearchResearch PersonnelResourcesSiteSocioeconomic StatusTestingTrustUnited States National Institutes of HealthVulnerable PopulationsWashingtonWorkbasecommunity clinicdata harmonizationdata submissiondistrustethnic minority populationexperiencehealth care availabilityimplementation studyimprovedmembermulti-site trialpopulation basedprogramspublic health relevanceracial and ethnicracial and ethnic disparitiesracial minorityrecruitself testingsexsocial health determinantsstandard measureuptakevaccine acceptancevaccine hesitancywillingness
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
122452563
UEI
VDFYLZPJEAV6
Project Start Date
29-July-2019
Project End Date
28-February-2023
Budget Start Date
01-September-2021
Budget End Date
28-February-2022
Project Funding Information for 2021
Total Funding
$570,000
Direct Costs
$375,000
Indirect Costs
$195,000
Year
Funding IC
FY Total Cost by IC
2021
NIH Office of the Director
$570,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R01MD013852-03S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01MD013852-03S2
Patents
No Patents information available for 3R01MD013852-03S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01MD013852-03S2
Clinical Studies
No Clinical Studies information available for 3R01MD013852-03S2
News and More
Related News Releases
No news release information available for 3R01MD013852-03S2
History
No Historical information available for 3R01MD013852-03S2
Similar Projects
No Similar Projects information available for 3R01MD013852-03S2